↓ Skip to main content

Chronic Myeloid Leukemia

Overview of attention for book
Cover of 'Chronic Myeloid Leukemia'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Cytogenetics of Chronic Myeloid Leukemia (CML)
  3. Altmetric Badge
    Chapter 2 The Biology and Pathogenesis of Chronic Myeloid Leukaemia
  4. Altmetric Badge
    Chapter 3 Epidemiology of Chronic Myeloid Leukaemia
  5. Altmetric Badge
    Chapter 4 Imatinib: The First-Line CML Therapy
  6. Altmetric Badge
    Chapter 5 CML Therapy: A Focus on Second- and Third-Generation Tyrosine Kinase Inhibitors
  7. Altmetric Badge
    Chapter 6 Adverse Events Associated with ATP-Competitive BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
  8. Altmetric Badge
    Chapter 7 Pharmacoeconomic Considerations for Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia
  9. Altmetric Badge
    Chapter 8 Standardization of Molecular Monitoring for Chronic Myeloid Leukemia: 2021 Update
  10. Altmetric Badge
    Chapter 9 Prognostic Scores for Patients with Chronic Myeloid Leukemia under Particular Consideration of Disease-Specific Death
  11. Altmetric Badge
    Chapter 10 A Review and an Update of European LeukemiaNet Recommendations for the Management of Chronic Myeloid Leukemia
  12. Altmetric Badge
    Chapter 11 The Role of Hematopoietic Stem Cell Transplantation in CML
  13. Altmetric Badge
    Chapter 12 CML End Phase and Blast Crisis: Implications and Management
  14. Altmetric Badge
    Chapter 14 Managing Pregnancy in Chronic Myeloid Leukaemia
  15. Altmetric Badge
    Chapter 15 Response-Related Predictors of Survival and of Treatment-Free Remission in CML
  16. Altmetric Badge
    Chapter 16 Discontinuation or Cessation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia Patients with Deep Molecular Response
Attention for Chapter 6: Adverse Events Associated with ATP-Competitive BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
Altmetric Badge

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Adverse Events Associated with ATP-Competitive BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
Chapter number 6
Book title
Chronic Myeloid Leukemia
Published by
Springer, Cham, January 2021
DOI 10.1007/978-3-030-71913-5_6
Book ISBNs
978-3-03-071912-8, 978-3-03-071913-5
Authors

Rea, Delphine

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 20%
Researcher 1 10%
Student > Ph. D. Student 1 10%
Unknown 6 60%
Readers by discipline Count As %
Medicine and Dentistry 2 20%
Immunology and Microbiology 1 10%
Nursing and Health Professions 1 10%
Unknown 6 60%